Physician profile
Joyce C Perfetti
NPI 1821378605
$3,312.97
in general payments reported to CMS, 2019-2025
13 companies · $244 in 2025
The $244 reported for 2025 was more than what 86% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.77 · 2022: $864 · 2023: $931 · 2024: $1,179 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,334 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,333.92 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $821.66 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $381.23 | 2022-2024 | Xarelto |
| Biosense Webster, INC. | $377.60 | 2022-2024 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $367.92 | 2023-2024 | Andexxa |
| Vapotherm INC | $299.71 | 2021-2023 | Vapotherm |
| Chiesi USA, INC. | $204.94 | 2022-2024 | Cleviprex |
| Abbott Laboratories | $167.73 | 2022 | |
| Csl Behring | $158.40 | 2023-2024 | Kcentra |
| Abiomed | $125.00 | 2025 | |
| Ucb, INC. | $124.99 | 2024 | Nayzilam |
| Grifols USA, LLC | $124.95 | 2023 | Hyperrab |
| Vertex Pharmaceuticals Incorporated | $118.70 | 2025 | |
| Pfizer INC. | $40.14 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Perfetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.